Scardino, Peter T.
Weill Cornell Medicine,
United States
2025 Rank: 6593
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 55 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6593 | 6987 |
| Total Cites | 63033 | 70707 |
| H-index | 129 | 137 |
| Hm-index | 45 | 47 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 464 | 478 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 942 | 977 |
| Number of Single+First+Last Authored Papers | 252 | 252 |
| Total Cites to Single+First+Last Authored Papers | 17103 | 18961 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 40804 | 43300 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.63 |
| Self-Citation Percentage |
10.85%
|
|
Scardino, Peter T.
Memorial Sloan-Kettering Cancer Center,
United States
2023 Rank: 5508
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 47 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5508 | 5749 |
| Total Cites | 58540 | 66139 |
| H-index | 126 | 135 |
| Hm-index | 44 | 46 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 455 | 469 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 924 | 959 |
| Number of Single+First+Last Authored Papers | 256 | 256 |
| Total Cites to Single+First+Last Authored Papers | 16352 | 18233 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 37413 | 39839 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.66 |
| Self-Citation Percentage |
11.49%
|
|
Scardino, Peter T.
Memorial Sloan-Kettering Cancer Center,
United States
2022 Rank: 5056
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 41 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5056 | 5244 |
| Total Cites | 55409 | 62691 |
| H-index | 122 | 132 |
| Hm-index | 43 | 44 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 446 | 460 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 910 | 945 |
| Number of Single+First+Last Authored Papers | 256 | 256 |
| Total Cites to Single+First+Last Authored Papers | 15838 | 17696 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 35209 | 37491 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.67 |
| Self-Citation Percentage |
11.62%
|
|
Scardino, Peter T.
Memorial Sloan-Kettering Cancer Center,
United States
2021 Rank: 4938
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 41 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4938 | 5044 |
| Total Cites | 53604 | 60704 |
| H-index | 120 | 131 |
| Hm-index | 42 | 44 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 432 | 446 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 870 | 905 |
| Number of Single+First+Last Authored Papers | 255 | 255 |
| Total Cites to Single+First+Last Authored Papers | 15384 | 17216 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 34032 | 36236 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.68 |
| Self-Citation Percentage |
11.70%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.